N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014871 |
| CAS No | NA |
| Mol.F. | C12H10N2O3 |
| Mol.Wt. | 230.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014872 |
| CAS No | NA |
| Mol.F. | C9H6N2O2 |
| Mol.Wt. | 174.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014873 |
| CAS No | NA |
| Mol.F. | C14H16N2O5 |
| Mol.Wt. | 292.3 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014874 |
| CAS No | NA |
| Mol.F. | C12H10N2O4 |
| Mol.Wt. | 246.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014875 |
| CAS No | NA |
| Mol.F. | C28H30ClN3O3 |
| Mol.Wt. | 492.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014876 |
| CAS No | NA |
| Mol.F. | C24H27N3O4 |
| Mol.Wt. | 421.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014877 |
| CAS No | 67776-06-1 |
| Mol.F. | C7H12N2O4S |
| Mol.Wt. | 220.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014878 |
| CAS No | NA |
| Mol.F. | C9H8N2O |
| Mol.Wt. | 160.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014879 |
| CAS No | NA |
| Mol.F. | C22H25ClN8O3S |
| Mol.Wt. | 517.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014880 |
| CAS No | NA |
| Mol.F. | C18H19ClN8O2S |
| Mol.Wt. | 446.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014881 |
| CAS No | NA |
| Mol.F. | C16H12Cl2N6O2S |
| Mol.Wt. | 423.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014882 |
| CAS No | 2135905-86-9 |
| Mol.F. | C20H21ClN8O2S |
| Mol.Wt. | 473.0 |
| INV STATUS | In Stock |
| CAT No | SRC-N014883 |
| CAS No | NA |
| Mol.F. | C20H21ClN8O2S |
| Mol.Wt. | 473.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014884 |
| CAS No | NA |
| Mol.F. | C22H25ClN8O4S |
| Mol.Wt. | 533.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014885 |
| CAS No | NA |
| Mol.F. | C25H29ClN8O4S |
| Mol.Wt. | 573.1 |
| INV STATUS | In Stock |
| CAT No | SRC-N014886 |
| CAS No | NA |
| Mol.F. | C25H42N2O19 |
| Mol.Wt. | 674.6 |
| INV STATUS | CUSTOM SYNTHESIS |